Express Pharma

Commercial Excellence 2.0

Bart Janssens, Partner and Director, BCG and Rahul Guha, Principal, BCG, in this three part article series, challenge some of the…

Train to Gain

Non compliance with GMP norms has proved costly for some of the biggest Indian pharmaceutical companies. Eager to avoid such…

Initiatives by IDMA

SV Veerramani, President,IDMA, Chairman and Managing Director, Fourrts (India) Laboratories elaborates on endeavours taken by IDMA…

An arduous endeavour?

Indian pharma companies are pushing for 'third country' status from the EU regulatory authorities for India's Schedule M and GMP…

Surviving a regulatory audit

In the regulatory compliance domain, one of the common failures cited by the regulatory authorities in their warning letters is…